The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 24, 2018
Filed:
Jan. 31, 2014
Applicant:
Wellstat Therapeutics Corporation, Gaithersburg, MD (US);
Inventors:
David M. Simpson, North Bethesda, MD (US);
Dennis Bryan Zerby, Chambersburg, PA (US);
Ming Lu, Bethesda, MD (US);
Reid W. von Borstel, Potomac, MD (US);
Rui Li, Darnestown, MD (US);
Julian Reading, Frederick, MD (US);
Stephen Wolpe, Boyds, MD (US);
Nureddin Aman, Herndon, VA (US);
Assignee:
Wellstat Therapeutics Corporation, Rockville, MD (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/4706 (2006.01); A61K 31/337 (2006.01); A61K 31/4164 (2006.01); A61K 31/437 (2006.01); A61K 31/44 (2006.01); A61K 31/4425 (2006.01); A61K 31/4709 (2006.01); A61K 31/4745 (2006.01); A61K 31/475 (2006.01); A61K 31/505 (2006.01); A61K 31/517 (2006.01); A61K 31/555 (2006.01); A61K 31/704 (2006.01); A61K 31/40 (2006.01); A61K 31/4184 (2006.01); A61K 31/472 (2006.01); A61K 31/4965 (2006.01); A61K 31/498 (2006.01); C07D 215/42 (2006.01); C07D 215/44 (2006.01); A01N 43/42 (2006.01); A01N 43/50 (2006.01); A01N 43/54 (2006.01); A01N 43/60 (2006.01); A01N 43/90 (2006.01); C07D 209/12 (2006.01); C07D 213/73 (2006.01); C07D 213/74 (2006.01); C07D 215/38 (2006.01); C07D 215/40 (2006.01); C07D 215/46 (2006.01); C07D 233/60 (2006.01); C07D 235/08 (2006.01); C07D 239/42 (2006.01); C07D 239/94 (2006.01); C07D 241/20 (2006.01); C07D 241/44 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A01N 43/42 (2013.01); A01N 43/50 (2013.01); A01N 43/54 (2013.01); A01N 43/60 (2013.01); A01N 43/90 (2013.01); A61K 31/337 (2013.01); A61K 31/40 (2013.01); A61K 31/4164 (2013.01); A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/4425 (2013.01); A61K 31/472 (2013.01); A61K 31/475 (2013.01); A61K 31/4706 (2013.01); A61K 31/4709 (2013.01); A61K 31/4745 (2013.01); A61K 31/498 (2013.01); A61K 31/4965 (2013.01); A61K 31/505 (2013.01); A61K 31/517 (2013.01); A61K 31/555 (2013.01); A61K 31/704 (2013.01); C07D 209/12 (2013.01); C07D 213/73 (2013.01); C07D 213/74 (2013.01); C07D 215/38 (2013.01); C07D 215/40 (2013.01); C07D 215/42 (2013.01); C07D 215/44 (2013.01); C07D 215/46 (2013.01); C07D 233/60 (2013.01); C07D 235/08 (2013.01); C07D 239/42 (2013.01); C07D 239/94 (2013.01); C07D 241/20 (2013.01); C07D 241/44 (2013.01); C07D 401/12 (2013.01); Y02A 50/409 (2018.01); Y02A 50/411 (2018.01); Y02P 20/582 (2015.11);
Abstract
Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.